Search

everythinglearnresearchcommunity

for

Search:↓

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

The methods accurately measured brain androgens, showing most 5α-androstane-3α,17β-diol comes from outside the brain, while androsterone is both transported and made in the brain.

A new method to make finasteride for hair loss treatment was developed.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Dutasteride is becoming a popular hair loss treatment, proving more effective than finasteride with similar side effects.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

A new treatment for hair loss shows promise with fewer side effects.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Human hair follicles can process steroid hormones like DHEA.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

A new compound effectively inhibits human 5α-reductase 1.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Finasteride worsens heart damage but reduces cell toxicity caused by nandrolone decanoate.